Related references
Note: Only part of the references are listed.Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells
Maria Antonietta Mazzola et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells
Maria Antonietta Mazzola et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System
Ippazio Cosimo Antonazzi et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies
Dnyandev G. Gadhave et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
LINGO-1 siRNA nanoparticles promote central remyelination in ethidium bromide-induced demyelination in rats
Alaa Eldin H. Youssef et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2019)
Intracerebral haemorrhage during alemtuzumab administration
Christina J. Azevedo et al.
LANCET NEUROLOGY (2019)
Risks and risk management in modern multiple sclerosis immunotherapeutic treatment
Luisa Klotz et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Preclinical Explorative Assessment of Dimethyl Fumarate-Based Biocompatible Nanolipoidal Carriers for the Management of Multiple Sclerosis
Pramod Kumar et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Myeloid Cell Plasticity in the Evolution of Central Nervous System Autoimmunity
David A. Giles et al.
ANNALS OF NEUROLOGY (2018)
Nose-to-brain peptide delivery - The potential of nanotechnology
Eleni Samaridou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Dimethyl fumarate: targeting glycolysis to treat MS
Stefano Angiari et al.
CELL RESEARCH (2018)
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Vassilis Bourganis et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain
Bhavin K Patel et al.
International Journal of Nanomedicine (2018)
Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
Martin Diebold et al.
JOURNAL OF AUTOIMMUNITY (2018)
Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis
Ivana Bjelobaba et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2018)
Reassessing B cell contributions in multiple sclerosis
Rui Li et al.
NATURE IMMUNOLOGY (2018)
Leukemia Inhibitory Factor-Loaded Nanoparticles with Enhanced Cytokine Metabolic Stability and Anti-Inflammatory Activity
Stephanie M. Davis et al.
PHARMACEUTICAL RESEARCH (2018)
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
Michael D. Kornberg et al.
SCIENCE (2018)
Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis
Hongliang He et al.
TRANSLATIONAL RESEARCH (2018)
Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophagemediated immunotherapy
Pengfei Zhao et al.
CHEMICAL SCIENCE (2018)
Effector T Cells in Multiple Sclerosis
Belinda J. Kaskow et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis
Robert A. LaMothe et al.
FRONTIERS IN IMMUNOLOGY (2018)
Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance
Takashi Kei Kishimoto et al.
FRONTIERS IN IMMUNOLOGY (2018)
Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide
Xiaopeng Mo et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Mononuclear phagocytes locally specify and adapt their phenotype in a multiple sclerosis model
Giuseppe Locatelli et al.
NATURE NEUROSCIENCE (2018)
Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-α siRNA provide a novel strategy for the experimental treatment of ulcerative colitis
Yuzhe Huang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Antibody Modified Nanoparticle-Mediated Delivery of miR-124 Regulates Apoptosis via Repression the Stat3 Signal in Mycobacterial-Infected Microglia
You Lang Zhou et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2018)
Multiple sclerosis: experimental models and reality
Hans Lassmann et al.
ACTA NEUROPATHOLOGICA (2017)
Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls
Delgertsetseg Chuluundorj et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Targeted delivery of nano-PTX to the brain tumor-associated macrophages
Lei Zou et al.
ONCOTARGET (2017)
Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior
Elisabetta Esposito et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice
Hongling Zhang et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Targeted delivery of glucocorticoids to macrophages in a mouse model of multiple sclerosis using inorganic-organic hybrid nanoparticles
Elena Montes-Cobos et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Multiple sclerosis: The resolving lesion revealed
Cedric S. Raine
JOURNAL OF NEUROIMMUNOLOGY (2017)
Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation
Katja Thomas et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance
Robert Kuo et al.
MOLECULAR THERAPY (2017)
Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates
Ryan M. Pearson et al.
MOLECULAR THERAPY (2017)
Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment
Alexandre C. C. Vieira et al.
NANOMEDICINE (2017)
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy
Derrick P. McCarthy et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles
Ejaj Ahmad et al.
NANOSCALE (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway
Chuan Qin et al.
STROKE (2017)
Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury
Wen Gao et al.
JOURNAL OF NANOBIOTECHNOLOGY (2017)
Human CD64-targeted non-viral siRNA delivery system for blood monocyte gene modulation
Seok-Beom Yong et al.
SCIENTIFIC REPORTS (2017)
Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model
Medhat A. Al-Ghobashy et al.
SCIENTIFIC REPORTS (2017)
CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases
Olusiji A. Akinrinmade et al.
BIOMEDICINES (2017)
An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis
Jonathan J. Cho et al.
BIOMATERIALS (2017)
Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10 years in responder multiple sclerosis patients
Michela Spadaro et al.
CLINICAL IMMUNOLOGY (2017)
Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy
Lanlan Liu et al.
BIOMATERIALS (2017)
Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis
Nielsen Lagumersindez-Denis et al.
ACTA NEUROPATHOLOGICA (2017)
Multiple sclerosis animal models: a clinical and histopathological perspective
Markus Kipp et al.
BRAIN PATHOLOGY (2017)
IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation
Lior Mayo et al.
BRAIN (2016)
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease
Andrew D. Greenhalgh et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Formulation and device design to increase nose to brain drug delivery
Zachary N. Warnken et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2016)
Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis
Monica A. Moreno et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages
Ranran Han et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Protective effects of monomethyl fumarate at the inflamed blood-brain barrier
Jamie L. Lim et al.
MICROVASCULAR RESEARCH (2016)
Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer
Mengmeng Niu et al.
MOLECULAR PHARMACEUTICS (2016)
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation
Sunita Yadav et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Origin, fate and dynamics of macrophages at central nervous system interfaces
Tobias Goldmann et al.
NATURE IMMUNOLOGY (2016)
Myeloid cells - targets of medication in multiple sclerosis
Manoj K. Mishra et al.
NATURE REVIEWS NEUROLOGY (2016)
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
Ulf Schulze-Topphoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Dimethyl fumarate blocks proinflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation
Victoria A. McGuire et al.
SCIENTIFIC REPORTS (2016)
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis
Mackenzie A. Michell-Robinson et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
Benedetta Parodi et al.
ACTA NEUROPATHOLOGICA (2015)
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries
Alessandro Dalpiaz et al.
ANTIVIRAL RESEARCH (2015)
Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF)
Sonja Rittchen et al.
BIOMATERIALS (2015)
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity
Erez Eitan et al.
EXPERIMENTAL NEUROLOGY (2015)
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
Andrew L. Croxford et al.
IMMUNITY (2015)
B Cells and Autoantibodies in Multiple Sclerosis
Anne-Katrin Proebstel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
Lazaros Belbasis et al.
LANCET NEUROLOGY (2015)
Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies
Dmitrij Hristodorov et al.
MABS (2015)
Solid Lipid Nanoparticles: A Potential Multifunctional Approach towards Rheumatoid Arthritis Theranostics
Joao Albuquerque et al.
MOLECULES (2015)
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
Felix Luessi et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
Felix Luessi et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
M2 polarization enhances silica nanoparticle uptake by macrophages
Jessica Hoppstaedter et al.
FRONTIERS IN PHARMACOLOGY (2015)
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases
Keren Turjeman et al.
PLOS ONE (2015)
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Roberto A. Maldonado et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Myeloid cells as target of fingolimod action in multiple sclerosis
Marco Di Dario et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease
Zoe Hunter et al.
ACS NANO (2014)
Multiple sclerosis and seizures: incidence and prevalence over 40 years
C. Lund et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis
Moa Fransson et al.
IMMUNOLOGY (2014)
Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis
Delgertsetseg Chuluundorj et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis
Zhilong Jiang et al.
IMMUNOLOGY LETTERS (2014)
Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application
Catarina Costa Moura et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases
Amit Singh et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Differential roles of microglia and monocytes in the inflamed central nervous system
Ryo Yamasaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Established and novel disease-modifying treatments in multiple sclerosis
A. H. Cross et al.
JOURNAL OF INTERNAL MEDICINE (2014)
RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course
Nuruddeen D. Lewis et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Treatment of Experimental Autoimmune Encephalomyelitis by Codelivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles
Kevin J. Peine et al.
MOLECULAR PHARMACEUTICS (2014)
Disease course heterogeneity and OCT in multiple sclerosis
L. J. Balk et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
Dean M. Wingerchuk et al.
MAYO CLINIC PROCEEDINGS (2014)
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE
John E. Mindur et al.
PLOS ONE (2014)
Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles
Daniel R. Getts et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis
Giuseppe Cappellano et al.
VACCINE (2014)
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
Marloes Prins et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
Jonathan Q. Tran et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases
Shambhunath Bose et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy
Bo Xiao et al.
BIOMATERIALS (2013)
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity
Natalie L. Payne et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Daphne Y. S. Vogel et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham et al.
NATURE GENETICS (2013)
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Veronique E. Miron et al.
NATURE NEUROSCIENCE (2013)
Type I and III interferons enhance IL-10R expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12
Bi-Sheng Liu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages
Hui-Rong Jiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation
Pieter J. Gaillard et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Alasdair J. Coles et al.
LANCET (2012)
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (vol 8, pg 889, 2009)
P. O'Connor
LANCET NEUROLOGY (2012)
Multifunctionalized CMCht/PAMAM Dendrimer Nanoparticles Modulate the Cellular Uptake by Astrocytes and Oligodendrocytes in Primary Cultures of Glial Cells
Susana R. Cerqueira et al.
MACROMOLECULAR BIOSCIENCE (2012)
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis
Daniel R. Getts et al.
NATURE BIOTECHNOLOGY (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Glatiramer Acetate Increases Phagocytic Activity of Human Monocytes In Vitro and in Multiple Sclerosis Patients
Refik Pul et al.
PLOS ONE (2012)
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis
Ada Yeste et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Christian Schulz et al.
SCIENCE (2012)
Shift work at young age is associated with increased risk for multiple sclerosis
Anna Karin Hedstrom et al.
ANNALS OF NEUROLOGY (2011)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Preactive Multiple Sclerosis Lesions Offer Novel Clues for Neuroprotective Therapeutic Strategies
Johannes M. van Noort et al.
CNS & Neurological Disorders-Drug Targets (2011)
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Greta Guarda et al.
IMMUNITY (2011)
Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis
Amit Rathore et al.
JOURNAL OF LIPOSOME RESEARCH (2011)
Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity
Refik Pul et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
The Application of High-Content Analysis in the Study of Targeted Particulate Delivery Systems for Intracellular Drug Delivery to Alveolar Macrophages
Ciaran Lawlor et al.
MOLECULAR PHARMACEUTICS (2011)
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration
Joanna Mikita et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Ivana Nikic et al.
NATURE MEDICINE (2011)
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Bahareh Ajami et al.
NATURE NEUROSCIENCE (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids
Yuval Avnir et al.
PLOS ONE (2011)
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (vol 8, pg 889, 2009)
P. O'Connor et al.
LANCET NEUROLOGY (2011)
Comparison of gene expression profiles between human and mouse monocyte subsets
Molly A. Ingersoll et al.
BLOOD (2010)
Nomenclature of monocytes and dendritic cells in blood
Loems Ziegler-Heitbrock et al.
BLOOD (2010)
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
J. M. Fletcher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Particle size affects the cellular response in macrophages
Hua Yue et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Activated Microglia Mediate Axoglial Disruption That Contributes to Axonal Injury in Multiple Sclerosis
Owain W. Howell et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Interferon-β mechanisms of action in multiple sclerosis
Suhayl Dhib-Jalbut et al.
NEUROLOGY (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
Pathogenic CD8+ T Cells in Multiple Sclerosis
Manuel A. Friese et al.
ANNALS OF NEUROLOGY (2009)
Multiple Sclerosis Distribution of Inflammatory Cells in Newly Forming Lesions
Andrew P. D. Henderson et al.
ANNALS OF NEUROLOGY (2009)
Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease
Irah L. King et al.
BLOOD (2009)
CCR2Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system
Alexander Mildner et al.
BRAIN (2009)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Nanoparticle-based targeted drug delivery
Rajesh Singh et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis
Joanna B. Tierney et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium
Alpesh Mistry et al.
JOURNAL OF DRUG TARGETING (2009)
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions
Ingo Bartholomaeus et al.
NATURE (2009)
PEG Minocycline-Liposomes Ameliorate CNS Autoimmune Disease
Wei Hu et al.
PLOS ONE (2009)
Preparation, Characterization and Evaluation of Targeting Potential of Amphotericin B-Loaded Engineered PLGA Nanoparticles
Manoj Nahar et al.
PHARMACEUTICAL RESEARCH (2009)
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1β in human monocytes and multiple sclerosis
Danielle Burger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction
Britta Engelhardt et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (vol 8, pg 889, 2009)
P. O'Connor et al.
LANCET NEUROLOGY (2009)
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
Paul O'Connor et al.
LANCET NEUROLOGY (2009)
Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination:: Long-term protective effects and enhanced efficacy of methylprednisolone formulations
Ralf A. Linker et al.
EXPERIMENTAL NEUROLOGY (2008)
Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: Role of intracellular osteopontin
Mari L. Shinohara et al.
IMMUNITY (2008)
The type IIFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
Beichu Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives
Raghavendra C. Mundargi et al.
JOURNAL OF CONTROLLED RELEASE (2008)
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
Mark A. Kroenke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Bahareh Ajami et al.
NATURE NEUROSCIENCE (2007)
Microparticles and nanoparticles for drug delivery
Daniel S. Kohane
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification
Sumio Chono et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Multiple sclerosis: a complicated picture of autoimmunity
Henry F. McFarland et al.
NATURE IMMUNOLOGY (2007)
Inhibition by mitoxantrone of in vitro migration of immunocompetent cells -: A possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis
Tea Kopadze et al.
ARCHIVES OF NEUROLOGY (2006)
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
S. Schilling et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
The epidemiology of multiple sclerosis in Europe
M. Pugliatti et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Oral fumaric acid esters for the treatment of active multiple sclerosis:: an open-label, baseline-controlled pilot study
S. Schimrigk et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
LA Boven et al.
BRAIN (2006)
Influence of particle size on the distributions of liposomes to atherosclerotic lesions in mice
S Chono et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Microorlial cell activation and proliferation precedes the onset of CNS autoimmunity
ED Ponomarev et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
The effects of interferon-β on interleukin-10 in multiple sclerosis patients
E Ersoy et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression
MR Kotter et al.
NEUROBIOLOGY OF DISEASE (2005)
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
FL Heppner et al.
NATURE MEDICINE (2005)
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
MH Barnett et al.
ANNALS OF NEUROLOGY (2004)
Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate
S Jung et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis
TL Sorensen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
Multiple sclerosis:: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo
MS Weber et al.
BRAIN (2004)
Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells - An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta
FT Bergh et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis
HJ Kim et al.
JOURNAL OF IMMUNOLOGY (2004)
Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage
KE Hill et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis
J Schmidt et al.
BRAIN (2003)
Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
M Fujino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
DJ Mahad et al.
SEMINARS IN IMMUNOLOGY (2003)
Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice - Susceptibility in multiple strains
S Gaupp et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
HP Hartung et al.
LANCET (2002)
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
T Kuhlmann et al.
BRAIN (2002)
Interferon-β treatment alters peripheral blood monocytes chemokine production in MS patients
M Comabella et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat
P Calvo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions
S Hulshof et al.
GLIA (2002)
CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated co-stimulation
AM Girvin et al.
JOURNAL OF AUTOIMMUNITY (2002)
Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis
JL McQualter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
A pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis
ES Huseby et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice
DM Sun et al.
JOURNAL OF IMMUNOLOGY (2001)
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis
DR Huang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Mechanisms of immunomodulation by glatiramer acetate
B Gran et al.
NEUROLOGY (2000)
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2
L Izikson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
BT Fife et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Multiple sclerosis and chronic autoimmune encephalomyelitis -: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
B Kornek et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Acute axonal injury in multiple sclerosis -: Correlation with demyelination and inflammation
A Bitsch et al.
BRAIN (2000)
Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
PW Duda et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
